Sio Gene Therapies SIOX

$ 0.42 2.09%

Quarterly report 2022-Q4
added 02-14-2023

Sio Gene Therapies Financial Statements 2011-2024 | SIOX

Annual Financial Statements Sio Gene Therapies

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	-	-	-	-	-	-	-	-	-
Shares	52.2 M	-	-	-	-	-	-	-	-	-	-
Historical Prices	0.67	2.64	2.93	10.6	11.5	102	101	-	-	-	-
Net Income	-3.33 M	-72.6 M	-129 M	-222 M	-181 M	-133 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.6 M	-72.2 M	-129 M	-221 M	-182 M	-133 M	-	-	-	-	-
Interest Expense	799 K	4.38 M	7.53 M	7.54 M	1.14 M	-	-	-	-	-	-
EBITDA	-31.7 M	-69.1 M	-119 M	-210 M	-181 M	-133 M	-	-	-	-	-
Operating Expenses	12.2 M	69.2 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.96 M	-	39.5 M	71.9 M	45.7 M	56.5 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Sio Gene Therapies

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	74 M	73.9 M	73.9 M	73.7 M	73.3 M	73 M	72.9 M	69.4 M	52.7 M	46.7 M	43.3 M	39.5 M	22.8 M	22.8 M	22.8 M	22.8 M	16.1 M	129 M	121 M	13.5 M	108 M	108 M	106 M	99.2 M	99.2 M	99.2 M	99.2 M	75 M	99.2 M	92.9 M	89.8 M	75 M	10 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.02 M	-15.5 M	-8.41 M	-13.3 M	-25.5 M	-58.6 M	-11.9 M	-11.9 M	-10.5 M	-10.5 M	-9.98 M	-8.59 M	-14 M	-14 M	-28.1 M	-28.1 M	-34.3 M	-34.3 M	-33.8 M	-25.3 M	-57.9 M	-69.1 M	-69.3 M	-69.3 M	-47.8 M	-47.8 M	-42.3 M	-38.1 M	-63.4 M	-63.4 M	-15.2 M	-25 M	-10.8 M	-10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-4.02 M	-15.5 M	-11.5 M	-	-25.5 M	-58.6 M	-33.1 M	-	-10.7 M	-10.7 M	-10.1 M	-8.56 M	-14 M	-14 M	-28 M	-28 M	-34.2 M	-34.2 M	-33.7 M	-	-57.9 M	-70.7 M	-66.7 M	-	-48 M	-127 M	-79.4 M	-	-62.6 M	-103 M	-40 M	-	-10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	464 K	785 K	321 K	-	-83 K	-105 K	-22 K	-	1 K	1 K	1 K	796 K	1.07 M	1.07 M	1.56 M	1.56 M	1.91 M	1.91 M	1.93 M	-	1.95 M	1.88 M	1.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-4.02 M	-15.4 M	-11.4 M	-	-25.5 M	-58.4 M	-33 M	-	-10.7 M	-9.85 M	-9.46 M	-8.07 M	-14 M	-12.9 M	-27.6 M	-27.6 M	-34.2 M	-32.1 M	-32.1 M	-	-57.9 M	-70.7 M	-66.4 M	-	-48 M	-127 M	-79.4 M	-	-62.6 M	-103 M	-40 M	-	-10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	4.48 M	16.3 M	11.8 M	13.1 M	25.4 M	58.5 M	33.1 M	11.9 M	10.6 M	10.6 M	9.55 M	9.83 M	13.7 M	13.7 M	27.6 M	27.6 M	32.4 M	32.4 M	32.1 M	24 M	55.4 M	68.7 M	65.2 M	65.2 M	48 M	48 M	41.5 M	37.9 M	62.6 M	62.6 M	15.1 M	24.9 M	10.8 M	10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.6 M	8.53 M	5.93 M	470 K	4.09 M	17.7 M	13.6 M	3.86 M	4.2 M	4.2 M	4.49 M	4.64 M	5.41 M	5.41 M	6.47 M	6.47 M	10.9 M	10.9 M	10.6 M	2.24 M	18 M	30.1 M	21.5 M	21.5 M	11.3 M	33.4 M	22.1 M	-	28.2 M	49.4 M	21.1 M	-	224 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency